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INTRODUCTION
A variety of agents, e .g. colchicine, that are known
to affect mitosis are also of value in providing in-
formation about motility of and within the cell .
Cytochalasins isolated from yeast by W . B. Turner,
and shown by Carter and others to inhibit mo-
tility and to block cell division, may be classified
as another antimotility group (1). One unique
feature of this compound is that it may be spe-
cific for microfibers since cytoplasmic cleavage of
mouse fibroblasts (1) and human lymphocytes (2)
is inhibited, but not nuclear division. Direct
evidence on the effect of cytochalasins on micro-
tubules and microfibers or its way of action is not
present.
We demonstrated that the mammalian plate-
let and nonmammalian thrombocyte contractile
mechanism as seen in clot retraction is remarkably
similar to the contractile systems controlling bio-
logical movement described for other cells (3),
and a theoretical model for contractile microfiber
formation in platelets was postulated (4) . Re-
cently, we described in glycerinated platelets
the complexing of a 60 A diameter microfiber
with heavy meromyosin that produced a distinct
arrowhead pattern similar to that described for
muscle actin or with microfibers from nonmuscle
cells (5). We now wish to report the effect of cyto-
chalasin B on the contractile system of human
and other mammalian platelets as seen in
retraction.
The results of incubating for 45 min 10 .tg of
cytochalasin-0.01 % DMSO/ml PRP are illus-
trated in Fig . 1, and they show that cytochalasin B
inhibits contraction of human PRP clots and the
onset and duration of retraction of calf PRP clots .
We assume that the difference in rates and degree
of contraction between the two species is a re-
flection of the reduced amount of cytochalasin
per cell in the calf experiment, and permeability
specificity. An equivalent inhibition of clot
retraction was obtained with 5 ug of cytochalasin
per ml PRP, but no alteration in clot retraction
was observed with the 1 ,ag of cytochalasin per
ml of PRP. (Experiments with cow and rabbit
PRP and with amphibian thrombocyte-rich
plasma produced parallel inhibition of clot re-
traction.) Varying the incubation time from 15
min to 1 hr had a negligible effect on the rate
and degree of clot retraction, and cytochalasin-
DMSO does not appear to affect protein synthesis
as measured by leucine-"C uptake .
These data demonstrate that cytochalasin B
produces an effect on platelet contractile system
that is similar to that observed when platelets
are incubated with 10-2 M colchicine or when
platelets are suspended in physiological saline
made with heavy water. Because of the tem-
porary inhibition of clot retraction by cytochala-
I Several cytochalasins differ in potency but have sin B, one assumption is that the cells are pro-
similar antimotility activity.
	
ducing sufficient contractile proteins to overcome
clot
METHODS
The preparation of the platelet-rich plasma (PRP)
and clot retraction was described previously (3);
the cytochalasin BI was dissolved in dimethyl sulfox-
ide (DMSO) following the procedure of Carter (1) .
Human and calf PRP suspensions were varied with
respect to number of cells, concentration of cyto-
chalasin, and time of incubation . All suspensions
were incubated at 37 ° C, and concentrations ex-
pressed throughout the report are final . Cell prepa-
rations were fixed for electron microscopy by using
standard glutaraldehyde-osmiurn tetroxide proce-
dures.
RESULTS AND DISCUSSION
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FIGURE 1 The effects of cytochalasin B (10 µg-0 .01% of DMSO/ml platelet suspension) on clot re-
traction compared with the control that is plotted as 100 0 /0. Control clot retractions at the end of 60 min
equalled 92 and 95% for human and calf platelet suspensions, respectively.
the action of cytochalasin, and only then does colchicine experiment is that the platelets treated
clot retraction occur at a rate equivalent to the with cytochalasin have microtubules present
controls. The one significant difference in the (Fig. 2), whereas published micrographs (3) of
present experiment when compared with the colchicine-treated platelets show a complete ab-
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30-sence of microtubules. These results indirectly
support our premise that platelet contractility
and clot retraction are functions of the micro-
fibers; the data also support the postulation of
Carter that cytochalasin suppresses biological
motility and that it may be specific for microfibers .
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FIGURE 2 Fine structure of platelets incubated in
plasma containing 10 jug of cytochalasin B-0.01%
DMSO/ml suspension. Aliquots were used for a platelet
pellet (Fig. 2 a) and clot (Fig. 2 b) . Note in both ex-
amples the presence of microtubules (arrow). Platelet
obtained from a clot does not show typical morpho-
logical alterations associated with activation, e.g.
pseudopod formation, degranulation, fibrogenesis.
X 45,000.
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